Add Yahoo as a preferred source to see more of our stories on Google. Moderna has been ordered to pay almost £44,000 over the adverts that appeared on X Moderna has been ordered to pay almost £44,000 ...
The Food and Drug Administration on Thursday granted full approval for Moderna's COVID-19 vaccine Spikevax in children aged 6 months through 11 years who are at an increased risk for COVID disease.
Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...
Moderna announced Thursday it is seeking emergency use authorization for its COVID-19 vaccine for children as young as 6 months old, which could allow children younger than age 5 to begin getting ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The approval is for children aged 6 months to 11 years ...
Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease CAMBRIDGE, MA / ACCESS Newswire / July 10, 2025 / ...
Based on new data, Moderna said it will ask the U.S. Food and Drug Administration to authorize the use of the vaccine in the younger age group in the coming weeks. Stacey Sager has CHICAGO -- Moderna ...
The US Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted unanimously to recommend Moderna’s COVID-19 vaccine as a two-dose series for ...
On Wednesday, the US Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted in favor of amending FDA’s emergency use authorization (EUA) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results